Sawgrass Asset Management LLC Abbott Laboratories Transaction History

Sawgrass Asset Management LLC

$920 Million
Q2 2024

A detailed history of Sawgrass Asset Management LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Sawgrass Asset Management LLC holds 100,933 shares of ABT stock, worth $11.4 Million. This represents 1.14% of its overall portfolio holdings.

Number of Shares

100,933

Previous 100,564 0.37%

Holding current value

$11.4 Million

Previous $11.4 Million 8.25%

% of portfolio

1.14%

Previous 1.27%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	BUY	$100.73 - $112.44 $37,169 - $41,490	369 Added 0.37%	100,933 $10.5 Million
Q1 2024 May 13, 2024	SELL	$109.52 - $120.96 $444,870 - $491,339	-4,062 Reduced 3.88%	100,564 $11.4 Million
Q4 2023 Feb 06, 2024	BUY	$90.19 - $110.4 $3 Million - $3.68 Million	33,316 Added 46.72%	104,626 $11.5 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $238,060 - $285,633	-2,492 Reduced 3.38%	71,310 $6.91 Million
Q2 2023 Jul 13, 2023	SELL	$100.78 - $112.29 $305,262 - $340,126	-3,029 Reduced 3.94%	73,802 $8.05 Million
Q1 2023 May 09, 2023	BUY	$96.86 - $114.01 $6.48 Million - $7.62 Million	66,854 Added 670.08%	76,831 $7.78 Million
Q3 2022 Nov 09, 2022	SELL	$96.76 - $112.03 $15,481 - $17,924	-160 Reduced 1.58%	9,977 $965,000
Q2 2022 Aug 04, 2022	SELL	$102.07 - $123.37 $101,457 - $122,629	-994 Reduced 8.93%	10,137 $1.1 Million
Q1 2022 May 18, 2022	BUY	$114.02 - $139.04 $1.27 Million - $1.55 Million	11,131 New	11,131 $1.32 Million
Q4 2021 Feb 03, 2022	SELL	$115.53 - $141.46 $1.36 Million - $1.66 Million	-11,750 Closed	0 $0
Q3 2021 Nov 04, 2021	SELL	$116.66 - $129.06 $880,316 - $973,886	-7,546 Reduced 39.11%	11,750 $1.39 Million
Q2 2021 Aug 05, 2021	SELL	$105.79 - $124.53 $9.84 Million - $11.6 Million	-93,013 Reduced 82.82%	19,296 $2.24 Million
Q1 2021 Apr 29, 2021	SELL	$108.84 - $128.23 $2.21 Million - $2.61 Million	-20,338 Reduced 15.33%	112,309 $13.5 Million
Q4 2020 Jan 22, 2021	SELL	$105.0 - $114.42 $354,690 - $386,510	-3,378 Reduced 2.48%	132,647 $14.5 Million
Q3 2020 Nov 02, 2020	SELL	$91.64 - $111.29 $1.87 Million - $2.28 Million	-20,457 Reduced 13.07%	136,025 $14.8 Million
Q2 2020 Jul 27, 2020	BUY	$76.57 - $98.0 $616,388 - $788,900	8,050 Added 5.42%	156,482 $14.3 Million
Q1 2020 May 15, 2020	SELL	$62.82 - $91.86 $7.44 Million - $10.9 Million	-118,426 Reduced 44.38%	148,432 $11.7 Million
Q4 2019 Feb 10, 2020	SELL	$78.51 - $87.4 $1.62 Million - $1.8 Million	-20,643 Reduced 7.18%	266,858 $23.2 Million
Q3 2019 Oct 30, 2019	SELL	$81.84 - $88.74 $20.9 Million - $22.7 Million	-255,258 Reduced 47.03%	287,501 $24.1 Million
Q2 2019 Jul 23, 2019	SELL	$72.88 - $85.0 $591,785 - $690,200	-8,120 Reduced 1.47%	542,759 $45.6 Million
Q1 2019 May 07, 2019	SELL	$66.22 - $80.06 $653,392 - $789,952	-9,867 Reduced 1.76%	550,879 $44 Million
Q4 2018 Feb 01, 2019	BUY	$65.56 - $74.27 $2.4 Million - $2.72 Million	36,629 Added 6.99%	560,746 $40.6 Million
Q3 2018 Nov 19, 2018	BUY	$60.81 - $73.36 $29.2 Million - $35.2 Million	479,455 Added 1073.52%	524,117 $38.4 Million
Q2 2018 Jul 26, 2018	SELL	$57.57 - $63.54 $23 Million - $25.4 Million	-400,000 Reduced 89.96%	44,662 $27.1 Million
Q2 2018 Jul 26, 2018	BUY	$57.57 - $63.54 $8.94 Million - $9.87 Million	155,363 Added 53.7%	444,662 $27.1 Million
Q1 2018 May 15, 2018	SELL	$56.27 - $63.62 $792,562 - $896,087	-14,085 Reduced 4.64%	289,299 $17.3 Million
Q4 2017 Feb 12, 2018	SELL	$53.68 - $57.47 $94,476 - $101,147	-1,760 Reduced 0.58%	303,384 $17.3 Million
Q3 2017 Nov 09, 2017	SELL	$48.06 - $53.64 $2.19 Million - $2.45 Million	-45,610 Reduced 13.0%	305,144 $16.3 Million
Q2 2017 Aug 11, 2017	BUY	N/A	350,754	350,754 $17.1 Million

Others Institutions Holding ABT

# of Institutions

3,137

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sawgrass Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sawgrass Asset Management LLC with notifications on news.

Account

Sawgrass Asset Management LLC Abbott Laboratories Transaction History